New Delhi, Dec 17 (PTI) Shares of dialysis services provider Nephrocare Health Services Ltd listed on Wednesday with a premium of nearly 7 per cent over the issue price of Rs 460.
The stock started trading
at Rs 491.70, a 6.89 per cent jump from the issue price, on the BSE. Later, it surged 8.41 per cent to Rs 498.70.
At the NSE, the stock was listed at Rs 490, reflecting a 6.52 per cent premium.
The company’s market valuation stood at Rs 4,762.67 crore.
The initial public offering (IPO) of Nephrocare Health Services Ltd got subscribed 13.96 times on the closing day of the share sale on Friday last week.
The Rs 871-crore IPO had a price band of Rs 438-460 per share.
The IPO comprised a fresh issue of shares aggregating to Rs 353.4 crore and an Offer For Sale (OFS) of 1.12 crore shares valued at Rs 517.6 crore at the upper end, taking the total issue size to Rs 871 crore.
Of the fresh issue, the company proposes to utilise Rs 129.1 crore for opening of new dialysis clinics in India; Rs 136 crore for payment of debt; and the balance for general corporate purposes.
Incorporated in 2009, NephroPlus has a global network of 519 clinics, including 51 clinics across the Philippines, Uzbekistan, and Nepal, as of September 30, 2025. PTI SUM DRR
